The new inhaler will be initially available in selected California dispensaries.
A metered dose inhaler (MDI) is a handheld device, which delivers a specific amount of medication in aerosol form rather than as a pill or capsule.
The MDI features a pressurized canister inside a plastic case, with a mouthpiece attached.
According to the company, the inhaler dosage is targeting 100 – 200 dose MDI with cannabinoid level variations ranging from 10mg, 25mg, up to 100mg THC, CBD, and other cannabinoid variables as patient/consumer analysis moves further down the road.
The MDI device provides the ingestion of the medication in a finer particle mist than the Nebulizer version which can be quickly absorbed by the lungs and spread into the blood stream.
The company will market the CBIS MDI Rescue Inhaler in all the US states, where marijuana is legal.
Cannabis Science co-founder Raymond Dabney said: "We couldn't be more excited to expand our company's reach to impact more patients than ever in a positive way.
"It surprises people that cannabis can actually improve lung volume and air flow rates, but that's exactly what studies show.
“The Cannabis Science Cannabinoid Based Inhalant will first be distributed in the State of California, but we plan to quickly roll the product out across the nation in legal States."
Image: The new CBIS MDI Rescue Inhaler. Photo: courtesy of Marketwired / Cannabis Science, Inc.
